Lorcaserin
CMOAPI ine huwandu hwakazara hwezvinhu zvakasvibirira zve lorcaserin, uye ine huwandu hwese hwekutonga hurongwa.

Zvigadzirwa zveCore
Ndekupi Kwokutenga Lorcaserin neVapakati vayo?
Iwe unogona kugadzira lorcaserin kutenga pazvitoro zvepamhepo. Iyo poda inowanikwa yakawanda kune vaongorori nevanoongorora. Kana chinangwa chako kuri kurasikirwa nemapaundi ekuwedzera nekuda kwekufutisa, unogona kutarisa lorcaserin iri kutengeswa online. Nekudaro, iwe ungangoda mushonga semhedzisiro yemitemo yakaoma neDFA.Kana iwe uchitsvaga lorcaserin kana ayo epakati, iwe unofanirwa kutarisa neCMOAPI kuti uwane unovimbika hwezvakachena zvigadzirwa. Makomputa edu akawana vimbiso yemhando yepamusoro.
( 1 )↗
Yakavimbika Tsime
Enda kunzvimbo
PubMed Central
Inoremekedzwa dhatabhesi kubva kuNational Institutes of HealthEnda kunzvimbo



Lorcaserin MIBVUNZO
Ini ndinotora sei belviq yemhedzisiro mhedzisiro?
Medza iyo yakawedzeredzwa-kuburitsa piritsi izere uye usapwanya, kutsenga, kana kuiputsa. Unogona kutora Belviq uine kana usina chikafu. Iwe unofanirwa kurasikirwa neinenge 5% yeako ekutanga uremu mukati memavhiki gumi nemaviri ekutanga kutora Belviq uye uchidya yakaderera koriori chikafu.Kurema kwakadii kwaunogona kurasikirwa nako nebelviq?
Lorcaserin, inoshandiswa pamwe chete nekudya uye kurovedza muviri, inoguma nekudzikira uremu zvine huremu ingangoita 12.9 lb (5.8 kg) ichienzaniswa ne5.6 lb (2.5 kg) ine placebo.Unotora nguva yakareba sei kutora belviq?
Unogona kutora Belviq uine kana usina chikafu. Iwe unofanirwa kurasikirwa neinenge 5% yeako ekutanga uremu mukati memavhiki gumi nemaviri ekutanga kutora Belviq uye uchidya yakaderera koriori chikafu. Fonera chiremba wako kana ukasarasikirwa neinenge 12% yehuremu hwako hwekutanga mushure mekutora mushonga kwevhiki gumi nembiri.Belviq inoita sei kuti unzwe?
Belviq inozivikanwa senge inosarudza serotonin 2C receptor agonist, zvinoreva kuti inogonesa chaiwo zvikamu zvehuropi hwako zvinoita kuti unzwe kuzara. Nzara shoma inotungamira mukudya kushoma, izvo zvinotungamira pakurasikirwa nehuremu.( 2 )↗
Yakavimbika Tsime
Enda kunzvimbo
PubMed Central
Inoremekedzwa dhatabhesi kubva kuNational Institutes of HealthEnda kunzvimbo
Ndeipi mhedzisiro yemalorcaserin?
Zvimwe zvinokanganisa Belviq zvinosanganisira: yakaderera ropa shuga (hypoglycemia), matambudziko epfungwa, kunonoka kurova kwemoyo, kutemwa nemusoro, dzungu, kukotsira, kunzwa kuneta, kuneta,Unogona here kunwa doro uchitora belviq?
Zvese uremu zvinodhaka zvinodyidzana nedoro? Haasi ese ekuremerwa uremu zvinodhaka zvine kudyidzana kwemishonga nedoro; semuenzaniso, lorcaserin (Belviq, Belviq XR) uye orlistat (Alli, Xenical) havanyore kudyidzana kwezvinodhaka zvinodhaka mune yavo yekunyora kunyorera.Ko belviq inogona kukonzera kurema?
Slim mhedzisiro. Vanhu vanotora mushonga kwegore vanogona kutarisira kurasikirwa chete 3 kusvika 3.7 muzana yehuremu hwavo, uye vanogona kuwana huremu kumashure, kutsvagisa kunoratidza. Mune kumwe kuyedzwa, varwere vanotora Belviq vakarasikirwa kusvika pa5 muzana yehuremu hwemuviri wavo mushure memwedzi gumi nemaviri, asi vakadzokazve makumi maviri neshanu muzana pakupera kwegore rechipiri.Ndeipi iri nani Contrave kana belviq?
Belviq uye Contrave ndeyemakirasi akasiyana emishonga. Belviq iserotonin 2C receptor agonist uye Contrave mubatanidzwa weanopikisana neopioid uye anodzvinyirira.Belviq inoshanda zvechokwadi here?
Vanhu vanotora mushonga kwegore vanogona kutarisira kurasikirwa chete 3 kusvika 3.7 muzana yehuremu hwavoIs belviq yakafanana nePhentermine?
Belviq (lorcaserin hydrochloride) uye Adipex-P (phentermine) anoshandiswa kurema manejimendi mune vakafutisa varwere mukuwedzera kune kudya uye kurovedza muviri. Belviq inoshandiswa kusingaperi uremu manejimendi.Belviq yakabviswa here?
IU.S. Chikafu neDrug Administration (FDA) yakumbira kuti mugadziri weBelviq, Belviq XR (lorcaserin) azvipire kubvisa huremu-kurasikirwa nemushonga kubva mumusika weUS.( 3 )↗
Yakavimbika Tsime
Enda kunzvimbo
PubMed Central
Inoremekedzwa dhatabhesi kubva kuNational Institutes of HealthEnda kunzvimbo
References
- Taylor, J., Dietrich, E., uye Powell, J. (2013). Lorcaserin yeUremu Management. Chirwere cheshuga, Metabolic Syndrome, uye Kufutisa.
- Hoy, SM (2013). Lorcaserin: Ongororo Yekushandisa Kwayo muKusingaperi Kurema Management. Zvinodhaka.
- Hess, R., uye Muchinjikwa, LB (2013). Iko Kuchengeteka uye Kubudirira kweLorcaserin mu Management yeKufutisa. Postgraduate mushonga.
- Brashier, DB, Sharma, AK, Dahiya, N., uye Singh, SK (2014). Lorcaserin: A Novel Antiobesity Zvinodhaka. Zvinyorwa zveFarmacology & Pharmacotherapeutics.
- Chan, EW uye al. (2013). Kubudirira uye Kudzivirirwa kwaLorcaserin muVakuru Vakuru: Meta-Ongororo ye1-Year Randomized Kudzora Miedzo (RCTs) uye Rondedzero Ongororo paPfupi-Nguva RCTs. Kuwedzeredza Ongororo.
- Nigro, SC, Luon, D., uye Baker, WL (2013). Lorcaserin: A Novel Serotonin 2C Agonist ye Kurapa Kufutisa. Ikozvino Kurapa Kwekutsvaga uye Maonero.